Skip to content

PolitiKit

Lobbying by Innovative Medicines Canada: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.

← Lobbying

Client of a consultant lobbyist

Innovative Medicines Canada

Meetings this Parliament
0
With MPs
0
Since Nov 2021
0
Active registrations
1

Registrations in effect

Consultant In effect since Aug 27, 2025

Consultant Stephen Sampson of Global Public Affairs

Consultant lobbyists

  • Stephen Sampson Former public office holder

    Formerly Legislative Assistant, Office of the Government House Leader, Privy Council Office (PCO) (2004–2006)

    Formerly Special Assistant (Policy), Office of the Minister of Transport, Transport Canada (2003–2004)

    Formerly Executive Assistant, Office of M.P. for Hamilton East - Stoney Creek, House of Commons (2001–2003)

    Formerly Legislative Assistant, Office of M.P. for Hamilton Mountain, House of Commons (2000–2001)

Institutions they may lobby: Global Affairs Canada (GAC), Health Canada (HC), House of Commons, Innovation, Science and Economic Development Canada (ISED), Patented Medicine Prices Review Board (PMPRB), Senate of Canada

What they're lobbying on (10)
  • Patented Medicine Prices Review Board with respect to the regulation of pricing of patented drug products
  • Patented Medicine Prices Review Board with respect to regulations of reporting obligations of patentees
  • Patent Act with respect to Canada's Access to Medicines Regime (ss. 21.01-21.09)
  • Patent Act regulations as they relate to the regulation of intellectual property for therapeutic products and the Patented Medicines (Notice of Compliance) Regulations
  • Patent Act as it relates to the regulation of intellectual property for therapeutic products
  • Innovation Strategy led by Industry, Science and Economic Development Canada, particularly with respect to the life sciences priority under the Innovation Strategy
  • Health care system policies or programs with respect to pharmaceuticals
  • Food and Drugs Act, specifically with respect to the approval, regulation and life-cycle management of therapeutic products
  • Food and Drug Regulations with respect to Data Protection under. C.08.004
  • Food and Drug Regulations specifically with respect to approval, regulation and life-cycle management of therapeutic products

Registration 814311-289532-11. Look it up in the official Registry

Reported meetings

No meetings reported since November 2021.

From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.